Medical News

RSS

A novel approach for funding children's genetic disease research

Parent Project Muscular Dystrophy together with Trisomy 18 Foundation are among 100 charities that earned a $25,000 grant during Round 1 of the Chase Community Giving Challenge on Facebook.

19 Jan 2010

US Oncology Foundation changes its name to Life Beyond Cancer Foundation

The US Oncology Foundation announced today that it is changing its name to the Life Beyond Cancer Foundation. This new name better captures the essence of hope that the organization aspires to provide to cancer patients and their families.

19 Jan 2010

Watson Laboratories files ANDA for Lidoderm

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lidocaine topical patch 8% prior to the expiration of U.S. Patent No. 5,827,529.

19 Jan 2010

Invatec's REEF HP PTA Balloon Catheter receives FDA marketing clearance

Invatec, a comprehensive innovator of cardiovascular products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its REEF HP™, a PTA Balloon Catheter, for use in peripheral high pressure dilatation procedures. The “lesion-specific” design of the balloon material is particularly useful in hard-to-dilate situations.

19 Jan 2010

Social factors still influence access to cancer services

People who develop the most common forms of cancer are still more likely to be diagnosed at a late stage in their disease if they live in a deprived area, new research has found.

19 Jan 2010

World Heart's Levacor VAD implant performed at INTEGRIS Baptist Medical Center

World Heart Corporation ("WorldHeart"), a developer of mechanical circulatory systems, announced today that the first U.S. implant of the Levacor Ventricular Assist Device ("VAD") was successfully performed at INTEGRIS Baptist Medical Center ("INTEGRIS") in Oklahoma City on Wednesday, January 13, 2010.

19 Jan 2010

AccessDNA and Informed Medical Decisions team up to provide telephone-based genetic counseling services

AccessDNA, Inc., the leading online consumer resource for genetic-related information, services, and support, today announced it has partnered with Informed Medical Decisions, Inc., the only nationwide-network of independent genetic counselors, to provide telephone-based genetic counseling services to AccessDNA’s fast-growing base of online users.

19 Jan 2010

GOP effort to recruit House Democrats to oppose health overhaul stalls

"A week after House Minority Whip Eric Cantor (R-Va.) announced an effort to persuade dozens of Democrats to abandon their support for health care reform, he appears to have made little headway, and several of the targets that he has identified said they have yet to hear from him," Roll Call reports.

19 Jan 2010

California limits HMO wait times

The regulations by the California Department of Managed Health Care, in the works for much of the last decade, will require that patients be treated by HMO doctors within 10 business days of requesting an appointment, and by specialists within 15.

19 Jan 2010

Corventis' NUVANT MCT System for detecting non-lethal arrhythmias receives FDA marketing clearance

Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.

19 Jan 2010

Leafy green vegetables, folate and multivitamins can prevent lung cancer in smokers

Leafy green vegetables, folate, and some multivitamins could serve as protective factors against lung cancer in current and former smokers, according to a study that is a first step in understanding a complex association.

19 Jan 2010

WHO, CDC issue H1N1 updates

Though H1N1 (swine flu) activity worldwide has slowed, the potential of a new wave of infections in the northern hemisphere in late winter or early spring remains viable, Keiji Fukuda, the WHO's top flu expert, said Monday at the start of the WHO's weeklong executive board meeting, Reuters reports.

19 Jan 2010

Novartis obtains exclusive worldwide rights to develop and commercialize Chiasma's TPE technology

Chiasma, Inc., a privately held biopharma company, announced today that it has granted Novartis an option to obtain exclusive worldwide rights to develop and commercialize the Company's Transient Permeability Enhancer (TPE) technology for use with certain related small molecule products either in development or currently marketed by Novartis.

19 Jan 2010

Dems plot health reform contingency plans if GOP wins Massachusetts Senate seat

Democrats are considering several courses of action to pass a health care reform bill if Massachusetts Senate hopeful Democrat Martha Coakley loses to Republican Scott Brown in a special election Tuesday, The Wall Street Journal reports.

19 Jan 2010

DURECT commences dosing in its POSIDUR Phase III clinical trial

DURECT Corporation announced today that it has begun dosing patients in its U.S. pivotal Phase III clinical trial to evaluate POSIDUR™ (SABER™-Bupivacaine), an investigational drug, for the treatment of post-surgical pain. The pivotal trial, referred to as BESST (Bupivacaine Effectiveness and Safety in SABER Trial), is an international, multi-center, randomized, double-blind, controlled trial evaluating the safety, efficacy, effectiveness, and pharmacokinetics of POSIDUR in patients undergoing general surgical procedures.

19 Jan 2010

KCI contributes advanced wound care products for the Haiti relief effort

Kinetic Concepts, Inc. today announced its contribution of more than $2 million dollars worth of advanced wound care products to the Haiti relief effort. The in-kind donation includes KCI’s industry-leading Active Healing SolutionsTM and Therapeutic Support SystemsTM products designed to help treat complex and hard-to-heal wounds. KCI will collaborate with Surgical Implant Generation Network (SIGN) and Project Medishare to place products in the hands of medical personnel in Haiti.

19 Jan 2010

Market Advisors Research predicts potential rise in VitaminSpice's share value

VitaminSpice is pleased to announce that Market Advisors Research has begun coverage of VitaminSpice with a very favorable report and predicts a potential rise in the valuation of the shares to $1.25 based on the continuing developments of the Company's fundamentals.

19 Jan 2010

National cross country HIV testing tour in Phoenix

The AHF/Magic Johnson ‘Testing America’ Tour, a six month, 48 state national cross country HIV testing tour, rolls into Phoenix, Arizona, for a testing event from 12 p.m. to 5 p.m., Tuesday, January 19th. Free testing will take place on AHF’s new, state-of-the-art ‘Testing America’ mobile HIV testing unit at the One Voice LGBT Community Center (725 West Indian Road, Phoenix, 85013).

19 Jan 2010

GenVec and Novartis collaborate to develop novel treatments for hearing loss and balance disorders

GenVec and Novartis will collaborate to discover and develop novel treatments for hearing loss and balance disorders. Preclinical results suggest that delivery of the atonal gene using GenVec's innovative adenovector technology may have the potential to restore hearing and balance function.

19 Jan 2010

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Affomix Corporation, a pioneer in high performance antibody technology, announced today a collaboration with City of Hope focused on establishing the clinical utility of “digital proteomics” with next generation sequencers. One of the nation’s top cancer research and treatment centers, City of Hope is a leading provider of molecular diagnostic testing services and an innovator in clinical genetics research.

19 Jan 2010